VVP
PFE icon

Venture Visionary Partners’s Pfizer PFE Stock Holding History

Venture Visionary Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,000
Closed -$280K – 574
2024
Q2 		$280K Hold
10,000
– – 0.01% 466
2024
Q1 		$278K Sell
10,000
-5,000
-33% -$139K 0.01% 463
2023
Q4 		$432K Buy
+15,000
New +$453K 0.02% 383

Other funds holding PFE

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Venture Visionary Partners's PFE Position: Q2 2026 in Review

Venture Visionary Partners increased its Pfizer (PFE) stake by 1.3% in Q2 2026, buying an estimated $54.8K and bringing the position to 161,492 shares worth $3.89M. The position accounts for 0.11% of the portfolio, ranked #174.

Venture Visionary Partners first reported a position in PFE in Q4 2019 and has held it in 27 quarters since. The position peaked at $14M in Q4 2022. 1,454 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Venture Visionary Partners held 161,492 shares of Pfizer worth $3.89M as of Q2 2026.
  • Venture Visionary Partners bought 2,096 Pfizer shares in Q2 2026, an estimated $54.8K.
  • Pfizer made up 0.11% of Venture Visionary Partners's portfolio in Q2 2026, its #174 holding.
  • Venture Visionary Partners first reported a position in Pfizer in Q4 2019 and has held it in 27 quarters since.
  • Venture Visionary Partners's Pfizer position peaked at $14M in Q4 2022.
  • 1,454 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Venture Visionary Partners's 13F filing for Q2 2026, filed 27 Jul 2026.